Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 453
Last updated 2025-04-13
Summary
This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.
Conditions
- Dermatologic Diseases
- Systemic Diseases With Cutaneous Manifestations
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
lead NIH
Principal Investigators
-
Edward W Cowen, M.D. · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eligibility
- Min Age
- 1 Day
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-08-22
- Primary Completion
- 2025-03-26
- Completion
- 2025-04-01
Countries
- United States
Study Locations
More Related Trials
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Digital Toolkit for Skin Diseases in LMICs: Part 2
NCT06292260 ·Status: RECRUITING ·Phase: NA
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
NCT00716014 ·Status: COMPLETED ·Phase: PHASE1
-
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
NCT05316805 ·Status: RECRUITING
-
Defining the Skin and Blood Biomarkers of Ichthyosis
NCT03417856 ·Status: ENROLLING_BY_INVITATION
-
Assessment of Dermatologists at Skin of Color Clinics
NCT03201029 ·Status: COMPLETED
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Personalized Therapy of Patients Suffering From Rare Genodermatoses
NCT05680974 ·Status: UNKNOWN
-
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
NCT00278525 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT02588625 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT03274076 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
NCT00442611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
NCT02283762 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
NCT05979506 ·Status: RECRUITING ·Phase: NA
-
Ruxolitinib in Seborrheic Dermatitis
NCT05787860 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis
NCT02921971 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Divozilimab in Patients With Systemic Scleroderma
NCT05726630 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
NCT03253666 ·Status: COMPLETED
-
Neurobiology of the Scalp in Seborrheic Dermatitis
NCT02349854 ·Status: COMPLETED
-
A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome
NCT05211830 ·Status: COMPLETED ·Phase: PHASE1/PHASE2